PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,000 | +200.0% | 2,851 | +143.5% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 1,171 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +200.0% | 1,171 | +57.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 746 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 746 | +31.6% | 0.00% | – |
Q1 2019 | $2,000 | -33.3% | 567 | -43.3% | 0.00% | – |
Q1 2018 | $3,000 | +200.0% | 1,000 | +233.3% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -66.7% | 300 | -62.9% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 809 | -33.1% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 1,209 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | +100.0% | 1,209 | +72.7% | 0.00% | – |
Q4 2015 | $2,000 | -50.0% | 700 | 0.0% | 0.00% | – |
Q3 2015 | $4,000 | -75.0% | 700 | -72.4% | 0.00% | – |
Q2 2015 | $16,000 | -52.9% | 2,533 | -46.2% | 0.00% | – |
Q1 2015 | $34,000 | -61.8% | 4,708 | -59.3% | 0.00% | – |
Q4 2014 | $89,000 | +4.7% | 11,576 | +1.9% | 0.00% | – |
Q3 2014 | $85,000 | -30.3% | 11,358 | -10.3% | 0.00% | – |
Q2 2014 | $122,000 | +15.1% | 12,668 | 0.0% | 0.00% | – |
Q1 2014 | $106,000 | +12.8% | 12,668 | +14.1% | 0.00% | – |
Q4 2013 | $94,000 | +1075.0% | 11,098 | +1009.8% | 0.00% | – |
Q3 2013 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |